DUBLIN--(BUSINESS WIRE)--The "Global Liquid Biopsy Market, Analysis and Forecast, 2017-2025 (Focus on Product Type, Therapeutic Application, End User, Market Share Analysis, Country Analysis and Competitive Landscape) " report has been added to Research and Markets' offering.
The global liquid biopsy market is anticipated to grow over $4,434 million by 2025.
With the growing prominence for non-invasive diagnostic procedures, the global liquid biopsy market is expected to register an impressive double digit growth rate in the forecast period 2016-2025. The global liquid biopsy market, by product, is being dominated by Kits & Consumables, the sub segment was reported to contribute approximately 63% to the global liquid biopsy market value in 2016. The sub segment is expected to maintain its dominating share and is estimated to contribute approximately 61% to the global liquid biopsy market value in 2025.
The liquid biopsy market is expected to grow at a near double digit annual growth rate. The abilities of liquid biopsy, such as minimal invasiveness, possibility of continuous monitoring of the patient's response towards treatment, and the monitoring of clonal mutations, combined with the growing prominence for precision medicine have fueled the growth of the liquid biopsy market.
The research study comprises in-depth analysis of the market trends and market size through different approaches. The entire market has been segmented and estimated in five different approaches, namely by product & services, by biomarker and technology, by cancer type, by end users, and by geography.
In terms of by products & services, the market has been segmented into kits & reagents, platforms & instruments, and services. In terms of by biomarker and technology the market has been segmented into circulating tumor cell (CTC), circulating tumor DNA (ctDNA), and extracellular vesicles (EV). In terms of by cancer type the market has been segmented into lung cancer, breast cancer, colorectal cancer, prostate cancer, and liver cancer. In terms of by end users the market has been tracked through hospital & laboratory, government & academic research centers.
Key Topics Covered:
1 Report Scope & Methodology
2 Market Overview
3 Market Dynamics
4 Competitive Insights
5 Global Liquid Biopsy Market, by Product
6 Global Liquid Biopsy Market, by Type of Biomarker
7 Global Liquid Biopsy Market, by Cancer Type
8 Global Liquid Biopsy Market, by End User
9 Global Liquid Biopsy Market, by Geography
10 Company Profiles
- ANGLE plc
- Adaptive Biotechnologies
- Bio-Rad Laboratories, Inc.
- Biocept, Inc.
- CareDx, Inc.
- Cynvenio Biosystems, Inc.
- Epic Sciences, Inc.
- F. Hoffmann-La Roche AG
- GUARDANT HEALTH, INC
- Genomic Health, Inc.
- Illumina, Inc.
- JOHNSON & JOHNSON
- MDxHealth, Inc.
- Menarini Silicon Biosystems, Inc.
- Myriad Genetics, Inc.
- Natera, Inc.
- NeoGenomics Laboratories, Inc.
- RainDance Technologies, Inc.
- Sysmex Corporation
- TROVAGENE, INC.
- Thermo Fisher Scientific
For more information about this report visit https://www.researchandmarkets.com/research/v427zv/global_liquid